OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/29/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization24,955 mln
Float1,791 mln
Earnings Date04/27/2026
EPS
1.02
Decent
P / E
13.88
Fair value
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.46
Borderline
Relative Strength
30
/ 100
Underperforming
Debt / Equity
0.41
Low leverage
Business Description
Astellas Pharma is a Japan-based pharmaceutical company that develops and sells medicines for serious conditions including prostate cancer, leukemia, kidney disease, and menopause-related symptoms, among others. The company serves patients across oncology, urology, ophthalmology, immunology, and women's health, distributing its products both domestically and around the world. Astellas also works with external partners to advance new treatment approaches, including RNA-based therapies and diabetes management tools. Founded in 1923 and headquartered in Chuo, Japan, the company has built a broad portfolio of specialty medicines over its century-long history.
